Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

Neurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett syndrome ...